— Know what they know.
Not Investment Advice

REKO.V TSXV

Reko International Group Inc.
1W: +2.2% 1M: -8.0% 3M: +3.4% YTD: +15.0% 1Y: +24.3% 3Y: -14.8% 5Y: +37.7%
C$4.60 ($3.22)
+0.00 (+0.00%)
 
TSXV · Industrials · Industrial - Machinery · Tech Score Neutral · Power 58 · C$25.2M mcap · 1M float · 0.074% daily turnover

Balance Sheet Trends

Total Assets
$57M -1.9% ▼
5Y CAGR: -1.5%
Total Liabilities
$15M -11.7% ▼
5Y CAGR: +0.4%
Shareholders Equity
$42M +2.0% ▲
5Y CAGR: -2.1%
Cash & Investments
$18M +57.4% ▲
5Y CAGR: +13.8%
Total Debt
$9M -14.2% ▼
5Y CAGR: -0.3%
Net Debt
-$9M -1709.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$6M$14M$12M$11M$18M
Short-Term Investments$4M$0$0$0$0
Cash & ST Investments$11M$14M$12M$11M$18M
Net Receivables$10M$21M$19M$12M$13M
Inventory$11M$0$0$6M$4M
Other Current Assets$0$26K$1M$822K-$3M
Total Current Assets$32M$36M$32M$30M$32M
Property, Plant & Equip.$27M$29M$28M$26M$24M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$300K$0$0$0$0
Total Non-Current Assets$30M$31M$30M$28M$25M
Total Assets$62M$67M$63M$58M$57M
— Liabilities —
Accounts Payable$3M$3M$2M$846K$1M
Short-Term Debt$6M$9M$4M$2M$4M
Deferred Revenue$1M$693K$655K$301K$35K
Other Current Liabilities$138K$0$0$2M$18K
Total Current Liabilities$12M$17M$9M$5M$9M
Long-Term Debt$3M$3M$8M$9M$5M
Other Non-Current Liab.$0$0$0$2M$0
Total Non-Current Liabilities$3M$3M$8M$12M$5M
Total Liabilities$15M$20M$17M$17M$15M
— Equity —
Common Stock$17M$16M$16M$16M$16M
Retained Earnings$28M$28M$28M$24M$25M
Accumulated OCI$0$0-$0$0$0
Total Stockholders Equity$47M$46M$46M$41M$42M
Total Liabilities & Equity$62M$67M$63M$58M$57M
— Key Metrics —
Total Debt$9M$13M$12M$11M$9M
Net Debt$3M-$1M-$76K-$475K-$9M
Total Investments$4M$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms